AI assistant
CVS HEALTH Corp — Director's Dealing 2011
Apr 8, 2011
29875_dirs_2011-04-08_94bd9a0c-af8a-4418-b148-0809c75b2fa1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2011-04-06
Reporting Person: MERLO LARRY J (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-06 | Common Stock | M | 144822 | $14.9625 | Acquired | 292107.8541 | Direct |
| 2011-04-06 | Common Stock | S | 144822 | $36.0042 | Disposed | 147285.8541 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-04-06 | Stock Option | $14.9625 | M | 144822 | Disposed | 2012-01-02 | Common Stock (144822) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 328448.7693 | Indirect |
| Common Stock (restricted) | 234469 | Direct |
| ESOP Common Stock | 6171.6477 | Indirect |
| Stock Unit | 204432.9091 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Credits | $1.00 | Common Stock (5220.6072) | 5220.6072 | Direct | |
| Stock Option | $12.5625 | 2013-01-09 | Common Stock (80000) | 80000 | Direct |
| Stock Option | $30.035 | 2013-04-03 | Common Stock (161359) | 161359 | Direct |
| Stock Option | $34.42 | 2014-04-02 | Common Stock (136089) | 136089 | Direct |
| Stock Option | $41.17 | 2015-04-01 | Common Stock (144144) | 144144 | Direct |
| Stock Option | $28.10 | 2016-04-01 | Common Stock (185572) | 185572 | Direct |
| Stock Option | $36.23 | 2017-04-01 | Common Stock (152988) | 152988 | Direct |
| Stock Option | $34.96 | 2018-04-01 | Common Stock (241150) | 241150 | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $36.00 and $36.08 per share.
F3: Each share credit is equivalent to one share; 1-for-1 conversion.
F4: Reflects 2002 and 2003 year end company match share credits of 33 and 27, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5: Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such timee as has been elected by the reporting person.
F6: Option became exercisable in three equal annual installments, commencing 4/3/2007.
F7: Option became exercisable in three equal annual installments, commencing 4/2/2008.
F8: Option became exercisable in three equal annual installments, commencing 4/1/2009.
F9: Option became exercisable in three equal annual installments, commencing 4/1/2010.
F10: Option became exercisable in three equal annual installments, commencing 4/1/2011.
F11: Option becomes exercisable in four equal annual installments, commencing 4/1/2012.